GAIA BioMedicine

PharmaceuticalsSeries BFukuoka-shi, Japangaia-biomed.com

Latest round

Series B

Last raised

Sep 2021

Total raised

$13M

Investors

4

About GAIA BioMedicine

Founded in 2015 and based in Fukuoka, Japan, GAIA BioMedicine Inc. as a spin-off venture of Kyushu University, is a biopharmaceutical company that uses technology and specializes in cell therapies and immunotherapies. Yoshikazu Yonemitsu, MD, PhD is a professor at the R&D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University. After working in the vascular surgery unit at Kyushu University Hospital, he served at the Gene Therapy Department of Imperial College London as a Wellcome Trust Fellow. He specializes in oncology, gene and cell therapy, and cardiovascular medicine and helped establish GAIA BioMedicine in October 2015. GAIA BioMedicine Inc. enables the production of NK-like cells that effectively eliminate solid tumors., HER2) that are expressed by cancer cells.

Who invested in GAIA BioMedicine

4 investors across 2 rounds

See all investors in GAIA BioMedicine

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 21, 2021

    Amount

    $12M

    Investors

    Locked

  2. Series B

    Jun 4, 2021

    Amount

    $0.9M

    Investors

    Locked

Questions about GAIA BioMedicine

Who invested in GAIA BioMedicine?

GAIA BioMedicine has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GAIA BioMedicine raised?

GAIA BioMedicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did GAIA BioMedicine last raise money?

GAIA BioMedicine's most recent round on record is a Series B, in Sep 2021.

What does GAIA BioMedicine do?

Founded in 2015 and based in Fukuoka, Japan, GAIA BioMedicine Inc.

Where is GAIA BioMedicine headquartered?

GAIA BioMedicine is headquartered in Fukuoka-shi, Japan.

Which VCs invest in companies like GAIA BioMedicine?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at GAIA BioMedicine's stage. Their profiles are linked below.

Raising like GAIA BioMedicine? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.